+Compare
ADMP
Stock ticker:
NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
28.87M

ADMP Price Prediction, Adamis Pharmaceuticals Corp AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

GET INTRADAY SIGNALS
ADMP Trading results, last 6 months
AI Robots NameP/L
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EST Dec 05, 2022

ADMP's RSI Oscillator leaves overbought zone

The 10-day RSI Indicator for ADMP moved out of overbought territory on November 18, 2022. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 instances where the indicator moved out of the overbought zone. In 22 of the 23 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 45 cases where ADMP's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on December 02, 2022. You may want to consider selling the stock, shorting the stock, or exploring put options on ADMP as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADMP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ADMP broke above its upper Bollinger Band on November 11, 2022. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

ADMP moved above its 50-day moving average on November 15, 2022 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ADMP crossed bullishly above the 50-day moving average on November 23, 2022. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ADMP advanced for three days, in of 226 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 90 cases where ADMP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ADMP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.142) is normal, around the industry mean (5.923). P/E Ratio (0.000) is within average values for comparable stocks, (48.008). ADMP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.500). ADMP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.024). P/S Ratio (19.920) is also within normal values, averaging (115.015).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADMP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published Earnings

ADMP is expected to report earnings to fall 33.33% to -1 cents per share on March 30

Adamis Pharmaceuticals Corp ADMP Stock Earnings Reports
Q4'22
Est.
$-0.02
Q3'22
Est.
$-0.03
Q2'22
Missed
by $0.02
Q1'22
Missed
by $0.04
Q4'21
Est.
$-0.05
The last earnings report on November 14 showed earnings per share of -2 cents, meeting the estimate of -2 cents. With 498.39K shares outstanding, the current market capitalization sits at 28.87M.
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Canopy Growth Corp (NASDAQ:CGC), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 2.11B. The market cap for tickers in the group ranges from 246 to 81.3B. MKKGY holds the highest valuation in this group at 81.3B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 3%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was -18%. EDNEF experienced the highest price growth at 219%, while NRXCF experienced the biggest fall at -40%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -36%. For the same stocks of the Industry, the average monthly volume growth was 25% and the average quarterly volume growth was -54%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 72
Price Growth Rating: 66
SMR Rating: 57
Profit Risk Rating: 92
Seasonality Score: 24 (-100 ... +100)
AI
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
11682 El Camino Real
Phone
+1 858 997-2400
Employees
15
Web
https://www.adamispharmaceuticals.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MATW31.74-0.05
-0.16%
Matthews International Corp
CVCY20.56-0.11
-0.53%
Central Valley Community Bancorp
FAST50.89-0.54
-1.05%
Fastenal Company
CVI33.23-1.31
-3.79%
CVR Energy
SIEN0.27-0.01
-4.10%
Sientra

ADMP and

Correlation & Price change

A.I.dvisor tells us that ADMP and HCM have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ADMP and HCM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADMP
1D Price
Change %
ADMP100%
-3.75%
HCM - ADMP
31%
Poorly correlated
+1.56%
OGI - ADMP
28%
Poorly correlated
-3.36%
TLRY - ADMP
26%
Poorly correlated
+2.18%
ACB - ADMP
25%
Poorly correlated
-2.86%
HEXO - ADMP
24%
Poorly correlated
-3.65%
More